XOMA Corp (XOMA)
24.15
-0.35
(-1.43%)
USD |
NASDAQ |
Apr 16, 14:58
XOMA Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2012 | 99.13% |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 | |
| December 31, 2010 | |
| September 30, 2010 | |
| June 30, 2010 | |
| March 31, 2010 | |
| December 31, 2009 | |
| September 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 | |
| December 31, 2008 | |
| September 30, 2008 | |
| June 30, 2008 | |
| March 31, 2008 | |
| December 31, 2007 | |
| September 30, 2007 | |
| June 30, 2007 | |
| March 31, 2007 | |
| December 31, 2006 | |
| September 30, 2006 | |
| June 30, 2006 |
| Date | Value |
|---|---|
| March 31, 2006 | |
| December 31, 2005 | |
| September 30, 2005 | |
| June 30, 2005 | |
| March 31, 2005 | |
| December 31, 2004 | |
| September 30, 2004 | |
| June 30, 2004 | |
| March 31, 2004 | |
| December 31, 2003 | |
| September 30, 2003 | |
| June 30, 2003 | |
| March 31, 2003 | |
| December 31, 2002 | |
| September 30, 2002 | |
| June 30, 2002 | |
| March 31, 2002 | |
| December 31, 2001 | |
| September 30, 2001 | |
| June 30, 2001 | |
| March 31, 2001 | |
| December 31, 2000 | |
| September 30, 2000 | |
| June 30, 2000 | |
| March 31, 2000 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Kinnate Biopharma Inc (DELISTED) | -- |
| Societal CDMO Inc (DELISTED) | 27.77% |
| Corcept Therapeutics Inc | 98.61% |
| Sarepta Therapeutics Inc | 88.87% |
| AbbVie Inc | 60.11% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -37.57% |
| Return on Assets | -26.93% |
| Return on Invested Capital | -30.59% |
| Profit Margin (Quarterly) | -1.10K% |
| Operating Margin (Quarterly) | -309.9% |
| Return on Net Operating Assets | -245.1% |